LPL Financial
VIR icon

LPL Financial’s Vir Biotechnology VIR Stock Holding History

LPL Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$466K Buy
52,000
+13,250
+34% +$106K ﹤0.01% 4817
2025
Q4 		$234K Buy
38,750
+2,600
+7% +$15.5K ﹤0.01% 5349
2025
Q3 		$206K Buy
36,150
+14,924
+70% +$76.3K ﹤0.01% 5330
2025
Q2 		$107K Buy
21,226
+6,817
+47% +$36.5K ﹤0.01% 5254
2025
Q1 		$93.4K Buy
+14,409
New +$128K ﹤0.01% 5056
2024
Q2 		– Sell
-30,734
Closed -$311K – 5150
2024
Q1 		$311K Buy
+30,734
New +$313K ﹤0.01% 4165
2022
Q4 		– Sell
-10,859
Closed -$209K – 4568
2022
Q3 		$209K Buy
+10,859
New +$276K ﹤0.01% 3896
2021
Q2 		– Sell
-5,598
Closed -$287K – 4311
2021
Q1 		$287K Buy
+5,598
New +$302K ﹤0.01% 3500

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return